Chlorine in PDB 5rys: EPB41L3 Pandda Analysis Group Deposition -- Crystal Structure of the Ferm Domain of Human EPB41L3 in Complex with Z1593306637

The structure of EPB41L3 Pandda Analysis Group Deposition -- Crystal Structure of the Ferm Domain of Human EPB41L3 in Complex with Z1593306637, PDB code: 5rys was solved by W.J.Bradshaw, V.L.Katis, J.A.Newman, F.Von Delft, C.H.Arrowsmith, A.M.Edwards, C.Bountra, O.Gileadi, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å)	61.23 / 1.75
Space group	P 21 21 21
Cell size a, b, c (Å), α, β, γ (°)	38.690, 77.630, 99.610, 90.00, 90.00, 90.00
R / Rfree (%)	21.1 / 24.8

The binding sites of Chlorine atom in the EPB41L3 Pandda Analysis Group Deposition -- Crystal Structure of the Ferm Domain of Human EPB41L3 in Complex with Z1593306637 (pdb code 5rys). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the EPB41L3 Pandda Analysis Group Deposition -- Crystal Structure of the Ferm Domain of Human EPB41L3 in Complex with Z1593306637, PDB code: 5rys:

Chlorine binding site 1 out of 1 in the EPB41L3 Pandda Analysis Group Deposition -- Crystal Structure of the Ferm Domain of Human EPB41L3 in Complex with Z1593306637


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of EPB41L3 Pandda Analysis Group Deposition -- Crystal Structure of the Ferm Domain of Human EPB41L3 in Complex with Z1593306637 within 5.0Å range: probe atom residue distance (Å) B Occ A:Cl401 b:31.4 occ:0.42 CL1 A:H0D401 0.0 31.4 0.4 C9 A:H0D401 1.7 30.9 0.4 C10 A:H0D401 2.7 31.4 0.4 C8 A:H0D401 2.7 32.0 0.4 CB A:PHE286 3.6 20.9 1.0 O A:TYR231 3.6 23.4 1.0 CG A:GLU283 3.6 22.6 1.0 C A:TYR231 3.7 21.9 1.0 CD2 A:PHE286 3.7 19.9 1.0 OG A:SER235 3.7 31.4 0.2 CA A:GLU283 3.7 23.0 1.0 N A:THR232 3.7 24.3 1.0 CA A:THR232 3.8 24.3 1.0 CG A:PHE286 3.8 19.4 1.0 O A:ALA282 3.8 22.1 1.0 N A:GLU283 3.9 22.2 1.0 C11 A:H0D401 4.0 31.8 0.4 C A:ALA282 4.0 24.1 1.0 C7 A:H0D401 4.0 32.1 0.4 OG1 A:THR232 4.1 24.8 1.0 CB A:TYR231 4.2 21.0 1.0 SG A:CYS206 4.2 22.1 1.0 CB A:SER235 4.2 30.0 0.2 CB A:SER235 4.2 30.2 0.2 CB A:GLU283 4.3 22.4 1.0 C6 A:H0D401 4.5 32.6 0.4 CA A:TYR231 4.5 21.2 1.0 CB A:THR232 4.6 25.2 1.0 CE2 A:PHE286 4.6 20.9 1.0 CB A:CYS206 4.7 21.4 1.0 OG A:SER235 4.7 31.0 0.2 CD1 A:PHE286 4.8 22.3 1.0 CB A:ALA282 4.8 23.4 1.0 CD A:GLU283 4.8 25.1 1.0 C A:GLU283 4.8 24.2 1.0 O A:GLU283 4.9 21.9 1.0 C A:THR232 4.9 23.6 1.0 CA A:PHE286 5.0 20.2 1.0 OE2 A:GLU283 5.0 25.3 1.0

W.J.Bradshaw, V.L.Katis, J.A.Newman, F.Von Delft, C.H.Arrowsmith, A.M.Edwards, C.Bountra, O.Gileadi. EPB41L3 Pandda Analysis Group Deposition To Be Published.